placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Transcriptional response of Candida albicans upon internalization by macrophages
When inflammation decreases, muscle mass increases, gut health improves, and stress hormones stabilize, GLP-1 and insulin begin working the way they were designed to
Since then, it has received FDA approval for the treatment of adults with cardiovascular risks and type 2 diabetes, as well as being the only GLP-1 receptor agonist to reduce the risk of worsening kidney disease and cardiovascular death in users
The science behind tirzepatide dosing: why milligrams matter at every level Understanding why the exact milligram amount in your 10-unit draw matters requires knowing how tirzepatide works at the molecular level